Reference
NICE. Adding pertuzumab to existing treatments after surgery for early breast cancer not cost effective, says NICE in draft guidance. Internet Document : 15 Jun 2018. Available from: URL: https://www.nice.org.uk/News/Article/adding-pertuzumab-to-existing-treatments-after-surgery-for-early-breast-cancer-not-cost-effective-says-nice-in-draft-guidance
Rights and permissions
About this article
Cite this article
Adjuvant pertuzumab not cost effective for early BC. PharmacoEcon Outcomes News 806, 35 (2018). https://doi.org/10.1007/s40274-018-5078-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5078-9